(Total Views: 87)
Posted On: 12/22/2021 3:15:50 PM
Post# of 21237

$LGND News Article - Ligand's Partner CStone Pharmaceuticals Receives Approval in China for Sugemalimab (Cejemly ) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer in Combination with Chemotherapy https://marketwirenews.com/news-releases/liga...04884.html


My Twitter: WhyteStocks